Related stories
Disc Medicine Reports Third-Quarter 2026 Financial Results
Disc Medicine reported third-quarter 2026 financial results and provided a business update.
M impact | EQUITY | Nov 05, 2026, 01:45 PM UTC
HCW Biologics Secures Up to $10.0 Million Through Debt Financing
HCW Biologics secured up to $10.0 million in cash through debt financing.
L impact | EQUITY | Nov 05, 2026, 01:45 PM UTC
NextNRG Executes Term Sheet to Acquire Indiana Site for Energy Center
NextNRG executed a term sheet to acquire a 33-acre Indiana site for its Lone Wolf Energy Center, with potential to support up to 70 MW of data center capacity.
M impact | EQUITY | Nov 05, 2026, 01:45 PM UTC
DiaMedica Therapeutics Schedules Q3 2026 Results and Business Update
The company says it will report third-quarter 2026 financial results and provide a business update on November 13, 2026.
M impact | EQUITY | Nov 05, 2026, 01:45 PM UTC
Middleby Names Steven Spittle to Succeed Timothy FitzGerald as CEO
Middleby said Steven Spittle, its chief commercial officer since February 2021, will become president and succeed Timothy FitzGerald as CEO.
L impact | EQUITY | Nov 05, 2026, 01:43 PM UTC
Frontdoor Reports Higher Q3 Adjusted Earnings and Revenue, Raises 2026 Outlook
Frontdoor reported increases in Q3 adjusted earnings and revenue and lifted its 2026 revenue outlook.
M impact | EQUITY | Nov 05, 2026, 01:42 PM UTC